Download full report with analyst certification and important disclosures
Oct 30 2025, 07:30 GMT
dsm-firmenich
Q3 update – broadly in line, guidance revised
- Sectors : Foods
- Companies : dsm-firmenich
DAVY VIEW
In a challenging environment, dsm-firmenich (DSFIR) has delivered Q3 organic sales growth of 2% with EBITDA flat year-on-year (yoy). Unsurprisingly, DSFIR has lowered its FY25 outlook – reflecting foreign exchange headwinds and the retracement in vitamin prices. For Q4, it is difficult to envisage a pick-up in organic sales growth for core activities. We expect to lower our FY25 EBITDA forecast of €2,334m by c.2%. The Animal, Nutrition & Health (ANH) disposal is expected to close in Q4.
